Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001551163-20-000092
Filing Date
2020-11-13
Accepted
2020-11-13 15:56:52
Documents
48
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10q.htm 10-Q 357646
2 f3101.htm EX-31 8444
3 f3102.htm EX-31 8049
4 0001551163-20-000092-3201.htm EX-32 4297
  Complete submission text file 0001551163-20-000092.txt   1839444

Data Files

Seq Description Document Type Size
5 sgbi-20200930.xml EX-101.INS 282827
6 sgbi-20200930.xsd EX-101.SCH 21659
7 sgbi-20200930_cal.xml EX-101.CAL 25517
8 sgbi-20200930_def.xml EX-101.DEF 55827
9 sgbi-20200930_lab.xml EX-101.LAB 141605
10 sgbi-20200930_pre.xml EX-101.PRE 125941
Mailing Address 352 SOUTH 200 WEST SUITE 3 FARMINGTON UT 84025
Business Address 352 SOUTH 200 WEST SUITE 3 FARMINGTON UT 84025 011 49 (40) 6093120
SANGUI BIOTECH INTERNATIONAL INC (Filer) CIK: 0001104280 (see all company filings)

EIN.: 841330732 | State of Incorp.: CO | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-29233 | Film No.: 201311318
SIC: 2834 Pharmaceutical Preparations